Venetoclax–based Low Intensity Therapy in Molecular Failure of NPM1-mutated AML
Carlos Jimenez-Chillon,Jad Othman,David Taussig,Carlos Jimenez-Vicente,Alexandra Martinez-Roca,Ing Soo Tiong,Manish Jain,James Aries, Seda Cakmak,Steven Knapper,Daniel Tuyet Kristensen,Vidhya Murthy, Joy Zacharoula Galani,Charlotte Kallmeyer,Loretta Ngu, David Veale,Simon Bolam,Nina Orfali,Anne Parker,Cara Manson, Jane Parker, Thomas Erblich,Deborah Richardson,Katya Mokretar,Nicola Potter,Ulrik Malthe Overgaard,Anne Stidsholt Roug,Andrew H. Wei,Jordi Esteve,Martin Jadersten,Nigel Russell,Richard Dillon BLOOD ADVANCES（2024）
Key words
Minimal Residual Disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper